We analyzed the clinical characteristics of the 4 cell cycle-related genes involved in CXP treatment of HCC, including CDK4, CHEK1, CCNB1, and CDKN2A, to further evaluate the clinical application value of CXP in HCC treatment. Here, CDK4 is linked to hepatocellular carcinoma.